WHO WE ARE

Foreword

The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is a bilateral clinical research partnership established in 2010 between the Ministry of Health (MoH) of the Republic of Indonesia and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health. Implementation of partnership activities is overseen jointly by the MoH Directorate of Advanced Health (Keslan) and the NIAID Division of Microbiology and Infectious Diseases.

With a shared commitment to advancing high quality clinical research on infectious diseases of global importance, INA-RESPOND conducts collaborative studies at sites across Indonesia. This research generates robust scientific evidence to inform clinical practice, strengthen public health policy, and support timely responses to infectious disease threats. All activities are coordinated by a central Secretariat in Jakarta staffed by clinical research professionals, a sophisticated BSL-2 Research Laboratory in Tangerang, and experienced clinical sites. Importantly, INA-RESPOND is integrated with broader NIAID and MoH research infrastructure, including the Indonesia Clinical Research Center (INA-CRC) and hospital-based Clinical Research Units (CRUs).

Scientific Impact

INA-RESPOND has conducted 11 clinical studies of varying complexity on multiple infectious disease threats, including HIV, multidrug resistant tuberculosis, COVID-19, schistosomiasis, and the causes of sepsis, acute fever requiring hospitalization, and pneumonia. Findings are published in international peer-reviewed scientific journals, and datasets and specimens remain available for future research. The partnership is also invested in enhancing the clinical research capacity of the MoH by hosting educational seminars and workshops, with past topics including protocol development, scientific writing, research ethics, HIV management, and laboratory testing. INA-RESPOND continues to evolve, expanding its research scope, strengthening its research readiness for future outbreaks, and generating evidence to support national and global health priorities.

Our Vision

To be a leading infectious disease clinical research group that minimizes the impact of outbreaks and improves the health of people in Indonesia, the United States, and the world.

Our Mission

To conduct high quality, collaborative clinical research studies on infectious diseases and launch rapid clinical research responses to outbreaks and epidemics.

Core Value

Our Core Values (BRIGHT)

Benefit and Responsiveness
Aligned with the research priorities of Indonesia, the United States, and the global health community.
Innovation
Advancing creative and integrated approaches in the design and implementation of research.
Goal Orientation
Focused on achieving the mission and long term impact of the partnership.
High Quality and Excellence
Committed to conducting scientifically rigorous and ethically sound infectious disease research.
Trust and Teamwork
Built on respect, transparency, accountability, communication, and collaboration.

Our Strategic Goals

Goal 1 – Science and Research

Generate new knowledge, disseminate results, and promote the utilization of research findings to improve infectious diseases clinical practice, policies, and guidelines

Goal 2 – Operations and Capability

Maintain INA-RESPOND as a collaborative partnership capable of conducting high-impact studies and launching a clinical research response

Goal 3 – Collaboration and Engagement

Leverage opportunities and collaborations to support, enhance, and promote INA-RESPOND

Institutional Framework

INA-RESPOND operates under multiple active bilateral agreements between Indonesia and the United States, namely:

Agreement on Scientific and Technological Cooperation signed on 29 March 2010
Memorandum of Understanding on Health Cooperation signed on 21 November 2024

The establishment and implementation of INA-RESPOND are further supported by key regulatory instruments issued by the MoH, including:

Minister of Health Decree No. 285/MENKES/SK/VIII/2013 on the INA-RESPOND Team
Minister of Health Decree No. HK.01.07/MENKES/248/2017 on the Indonesia Infectious Disease Research Team
Director General of Advanced Health Decree No. HK.02.02/D/3167/2025 on the INA-RESPOND Secretariat